Recent Anti-VEGF Market trends show significant innovation in the field of biopharmaceutical therapies designed for retinal disease management. Pharmaceutical companies are focusing on improving treatment effectiveness while minimizing patient discomfort and treatment frequency. The development of biosimilar anti-VEGF drugs is also gaining attention as healthcare systems seek more affordable...